Zhongjun Cheng
About Zhongjun Cheng
Zhongjun Cheng is a Scientist specializing in Downstream Process Development at Bristol-Myers Squibb in New York, with extensive experience in cancer treatment research and a strong background in biophysics and molecular biology.
Title: Scientist Downstream Process Development
Zhongjun Cheng currently holds the title of Scientist in Downstream Process Development at Bristol-Myers Squibb. Based in New York, New York, Cheng brings extensive expertise to this role, leveraging years of experience in biophysics and molecular biology to advance pharmaceutical development.
Education and Expertise
Zhongjun Cheng earned a Bachelor of Science from Zhengzhou University between 1996 and 2000. This foundational education was followed by a Doctor of Philosophy in Biophysics from the University of Science and Technology of China, where Cheng studied from 2001 to 2006. These academic achievements have equipped Cheng with a strong grounding in biophysics and molecular biology, essential for a career in pharmaceutical research and development.
Professional Background
Cheng's professional background includes significant tenures at prestigious institutions. As a graduate student at the Institute of Biophysics, Chinese Academy of Science in Beijing (2004-2006), Cheng gained early research experience. Following this, Cheng worked at Memorial Sloan Kettering Cancer Center, initially as a Research Fellow from 2007 to 2012 and then as a Research Associate from 2012 to 2014. Cheng has been with Bristol-Myers Squibb since July 2014, demonstrating a long-term commitment to advancing pharmaceutical research.
Experience in Cancer Research
Zhongjun Cheng's work at Memorial Sloan Kettering Cancer Center, spanning seven years from 2007 to 2014, provided extensive experience in cancer research and development. During this period, Cheng contributed to significant research projects, enhancing the understanding and treatment of cancer. This experience has been pivotal in shaping Cheng's career and expertise in downstream process development.
Current Role at Bristol-Myers Squibb
Since July 2014, Zhongjun Cheng has been a key member of the Bristol-Myers Squibb team in New York. In the role of Scientist specializing in Downstream Process Development, Cheng applies in-depth knowledge of biophysics and molecular biology to improve and innovate pharmaceutical processes. This long-term role highlights Cheng's significant contributions to the field over the past nine years, reflecting deep expertise and sustained professional growth.